Anti-hENT1 Monoclonal Antibody

Anti-hENT1 Monoclonal Antibody

IHC595-100

$170.00 You Pay

Supplier: GenomeMe

Description:

The human Equilibrative Nucleoside Transporter 1 (hENT1) mediates the cellular uptake of physiologic nucleosides, including adenosine, as well as many anti-cancer drugs including gemcitabine, cytarabine, and decitabine. De ciency of hENT1 can lead to resistance of such drugs, and the abundance of hENT1 protein in the plasma membrane is a major indicator of the e ciency and clinical outcome of these anti-cancer nucleosides.

Specifications:

Clone IHC595
Source Mouse Monoclonal
Positive Control

Adrenal Cortex, Kidney, Thyroid, Tonsil, Normal Pancreas
Dilution Range 1:100 - 1:400

IFU & SDS:

Figure: GeneAbTM  hENT1 [IHC595] on Thyroid Cancer

References

  1. Chow L, et al. Mod Pathol. 2005; 18:558-64.
  2. Santini D, et al. Curr Cancer Drug Targets. 2011; 11:123-9.
  3. Sundaram M, et al. J Biol Chem. 2001; 276:45270-5.
  4. Borbath I, et al. Eur J Cancer. 2012; 48:990-6.
  5. Greenhalf W, et al. J Natl Cancer Inst. 2014; 106:djt347.
  6. Wu L, et al. J Transl Med. 2016; 14:66.